Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metadoxine in non-alcoholic steatohepatitis
NCT02541045Phase 3Withdrawn
- Sponsor
- Hospital General de México "Dr. Eduardo Liceaga"
- Start
- Aug 2015
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Metadoxine in Nonalcoholic steatohepatitis (NASH), sponsored by Hospital General de México "Dr. Eduardo Liceaga". Planned start Aug 2015; status: withdrawn.
02
Drugs
Metadoxine
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT02541045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02541045.